MedTrace Logo

Evaluation of the Effectiveness and Safety of Keeogo™ Dermoskeleton in Subjects With Mobility Impairments Due to Stroke

NCT03986320 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-10-29

No results posted yet for this study

Summary

A multi-site, interventional, non-comparative, single-arm trial to evaluate the safety of the Keeogo™ Dermoskeleton in subjects with hemiparesis due to ischemic or hemorrhagic stroke.

Conditions

  • Stroke, Ischemic
  • Stroke Hemorrhagic
  • Stroke
  • Hemiparesis
  • Cerebral Vascular Accident

Interventions

DEVICE

Keeogo™ Dermoskeleton

This device is intended for use in rehabilitation institutions to assist individuals with hemiparesis due to stroke who are able to stand and initiate a step in performing ambulatory functions.

Sponsors & Collaborators

  • B-Temia, Inc.

    lead INDUSTRY

Principal Investigators

  • Arun Jayaraman, PT, PhD. · Shirley Ryan Ability Lab (SRA)

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-22
Primary Completion
2020-03-31
Completion
2020-09-30
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03986320 on ClinicalTrials.gov